कंपनी का अवलोकन
Retractable Technologies, Inc. is an entity dedicated to the design, development, manufacturing, and marketing of safety syringes alongside other safety medical products specifically for the healthcare profession. The company operates within the healthcare sector, specifically focusing on the medical instruments and supplies industry, which implies a reliance on regulatory compliance and specialized manufacturing capabilities to serve hospitals, clinics, and ambulatory care settings across the United States, North America, South America, and international markets. The scale of the business is characterized by a market capitalization of $20.37M and an annual revenue (TTM) of $38.27M, while the specific employee count is not disclosed in available data. These valuation and revenue figures indicate that Retractable Technologies, Inc. functions as a small-cap enterprise with a market capitalization significantly below one billion dollars, suggesting a position in the market where it may be more sensitive to capital market fluctuations compared to large-cap peers, yet maintains a revenue base sufficient to fund operations despite its current profitability challenges.
वित्तीय स्वास्थ्य
The company reported a revenue (TTM) of $38.27M, yet recorded a net income (TTM) of -$12,795,674 and an EBITDA of -$12,454,825, revealing a substantial gap between top-line sales and bottom-line earnings that points to an aggressive or inefficient cost structure relative to revenue generation. This negative net income indicates that operating expenses and other deductions have exceeded total revenue, resulting in a significant loss for the period under review. Furthermore, the free cash flow stands at -$2,183,980, which signifies a cash burn scenario where operational cash outflows exceed inflows, thereby limiting the company's immediate financial flexibility and its ability to fund capital expenditures or acquisitions without external financing. The margin profile reflects this financial pressure with a gross margin of 0.1%, an operating margin of -71.6%, and a profit margin of -32.8%, illustrating that while the company generates some revenue from sales, its cost of goods sold and operating expenses are eroding profitability to a severe degree. In terms of liquidity and leverage, the company holds $36.97M in cash against only $1.20M in debt, and the debt-to-equity ratio is recorded at 1.62, creating a complex balance sheet picture where high cash reserves coexist with a debt-to-equity metric that technically suggests leverage, though the massive cash position acts as a buffer against this liability. The current ratio is a robust 6.57, indicating that the company possesses ample current assets relative to its current liabilities, which suggests strong short-term liquidity and the ability to meet obligations as they come due. Additionally, the return on equity is -15.6% and the return on assets is -8.3%, metrics that reveal that management has not yet generated positive returns on the capital invested in the business or the assets employed, highlighting the challenges in capital allocation efficiency during this growth or restructuring phase.
मूल्यांकन आकलन
The trailing P/E ratio and forward P/E ratio are both listed as N/A, which implies that the absence of positive earnings prevents the calculation of a traditional price-to-earnings multiple, rendering standard valuation comparisons based on earnings power impossible at this time. Consequently, the price-to-book ratio of 0.27 indicates that the market is valuing the company at a significant discount to its book value, suggesting that investors are pricing in substantial risks or expecting a long path to profitability before the stock price appreciates. The price-to-sales ratio is 0.53, and the EV/EBITDA is 1.22, which provides alternative valuation perspectives that show the company trades at less than half of its sales and has a very low enterprise value relative to earnings before interest, taxes, depreciation, and amortization, though the negative EBITDA complicates the direct interpretation of the EV/EBITDA metric. The stock has traded between a 52-week high of $1.14 and a 52-week low of $0.62, meaning the current price sits at a specific point within this range, reflecting market sentiment that fluctuates based on the company's ongoing financial performance and sector conditions. The beta value of 1.26 indicates that the stock's price volatility is 26% higher than the broader market, suggesting that Retractable Technologies, Inc. experiences amplified price swings during periods of market turbulence compared to a standard market index.
Growth & Income
The company achieved a revenue growth (YoY) of 4.0%, while the earnings growth (YoY) is N/A due to the reported net losses, implying that top-line expansion is currently decoupled from bottom-line improvement as the firm works through operational inefficiencies or one-time costs. Since the company does not pay dividends, evidenced by a dividend yield of N/A and a payout ratio of 0.0%, it does not distribute earnings to shareholders, which is consistent with a firm that must reinvest any available resources or raise capital to sustain operations and fund future growth initiatives. The overall growth and income profile is defined by moderate revenue expansion in a defensive healthcare sector but is currently constrained by negative earnings and cash flow, resulting in a scenario where shareholder returns are driven solely by potential capital appreciation rather than dividend income or earnings growth.